| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 76.7661 | 71 |
| GSM780708 | Untreated after 4 days (C2_1) | 79.5358 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 79.1417 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 68.2988 | 68 |
| GSM780720 | Untreated after 4 days (C2_2) | 76.0087 | 71 |
| GSM780721 | Untreated after 4 days (C3_2) | 87.4167 | 73 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 70.6399 | 69 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 72.5404 | 70 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 73.1988 | 70 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 69.2446 | 69 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 73.2732 | 70 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 76.325 | 71 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 86.0684 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 85.5328 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 80.2567 | 72 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 83.6852 | 72 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 73.4371 | 70 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 69.353 | 69 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 64.5712 | 67 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 75.7515 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 89.472 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 73.9605 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 71.3175 | 69 |